Brief: Dishman Carbogen Amcis Says Unit Completed Us FDA Inspection Of Manufacturing Sites Located In Hunzenschwil And Aarau, In Switzerland
27/06/2024 16:31
June 27 (Reuters) - Dishman Carbogen Amcis Ltd
DSHM.NS :
* UNIT COMPLETED US FDA INSPECTION OF MANUFACTURING SITES
LOCATED
IN HUNZENSCHWIL AND AARAU, IN SWITZERLAND
* INSPECTIONS AT BOTH SITES WERE CONCLUDED WITH NO FORM 483
AND
CLASSIFIED AS NO ACTION INDICATED
Source text for Eikon: ID:nNSE9qgPW2
Further company coverage: DSHM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis